Philips launches next-generation image-guided therapy platform

MedTech News: Philips announced its next-generation Philips Azurion image-guided therapy platform, marking an important step forward in optimising clinical and operational lab performance and expanding the role of image-guided interventions in the treatment of patients.

Intuitive, integrated and efficient, the next-generation Azurion advances the capabilities of the platform to further improve the quality and efficiency of interventional procedures. The Azurion platform has already achieved rapid global adoption and has been used in well over two million procedures worldwide since its introduction three years ago. 

In the past few decades, clinical practices around the world have evolved to successfully treat more patients and perform more complex procedures in interventional labs. However, with more staff and technologies involved during these procedures, interventional lab environments can become crowded and cluttered. In order to enhance clinician focus and control during procedures, Philips has integrated all the essential lab systems and tools into this new version of the Azurion platform, making it an important step forward in lab integration. 

An industry-first, the Philips Azurion image-guided therapy platform now integrates control of imaging, physiology, hemodynamic and informatics applications, as well as intuitive control of the gantry, at the tableside, allowing clinicians to control all compatible applications from a single touch screen while performing procedures. This can eliminate the need for clinicians to leave the sterile field and step into an adjacent control room, as well as supporting faster and better informed decision making. 

With this next-generation Azurion platform, Philips is also introducing a new 3D imaging solution called SmartCT. With SmartCT, users are guided through the image acquisition and can review and interact with the acquired CT-like 3D images on the tableside touch screen module using 3D visualisation and measurement tools.

“This next-generation Azurion makes routine cardiovascular procedures more efficient and supports the development of new minimally-invasive techniques to treat complex diseases such as stroke, lung cancer and spine disorders,” said Ronald Tabaksblat, General Manager Image Guided Therapy Systems at Philips,

With the new Azurion platform, clinicians can easily switch between imaging, physiology, hemodynamic and informatics applications, including SmartCT and IntraSight – a comprehensive suite of clinically proven iFR, FFR, IVUS and co-registration modalities.